Fund HoldingsBain Capital Life Sciences Investors, LLC

Total Portfolio Value
$799.27M
Total Bought
$131.36M
Total Sold
$25.39M
Net Transaction
+$105.97M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
CIDARA THERAPEUTICS INC703,0802,500,680+1,797,60015,144121,80815.24%+106,664
UPSTREAM BIO INC2,295,3222,439,538+144,21614,04726,7863.35%+12,739
CABALETTA BIO INC2,760,8889,677,125+6,916,2373,82414,7091.84%+10,885
TANGO THERAPEUTICS INC(TNGX)2,712,0082,712,00803,71513,8851.74%+10,170
SOLID BIOSCIENCES INC7,911,6697,911,669029,27338,5304.82%+9,257
NUVALENT INC1,447,2671,447,2670102,640110,42613.82%+7,786
RAPID MICRO BIOSYSTEMS INC8,434,5608,434,560022,26729,0993.64%+6,832
PHARVARIS N V
COM
3,303,3813,303,381051,86358,1407.27%+6,276
KYVERNA THERAPEUTICS INC3,368,3703,368,37006,50110,3411.29%+3,840
OLEMA PHARMACEUTICALS INC(OLMA)6,843,9546,843,954025,73329,1553.65%+3,422
ANNEXON INC(ANNX)5,249,0695,249,069010,13112,5981.58%+2,467
ATEA PHARMACEUTICALS INC2,485,6382,485,63807,4328,9481.12%+1,516
X4 PHARMACEUTICALS INC0563,859+563,85901,0710.13%+1,071
CENTURY THERAPEUTICS INC5,410,3615,410,36102,5753,0230.38%+447
INVIVYD INC1,799,5951,799,59501,0891,2870.16%+197
NEWAMSTERDAM PHARMA COMPANY
*W EXP 99/99/999
100,000100,00008998000.10%-99
C4 THERAPEUTICS INC1,111,9101,111,91001,7791,5900.20%-189
XILIO THERAPEUTICS INC4,566,8174,566,81703,3083,1050.39%-203
MERSANA THERAPEUTICS INC8,663,6738,663,67302,9822,5640.32%-418
NAUTILUS BIOTECHNOLOGY INC1,072,4210-1,072,4219230-923
DIANTHUS THERAPEUTICS INC(DNTH)2,689,7072,482,250-207,45748,79146,2445.79%-2,547
X4 PHARMACEUTICALS INC16,915,7840-16,915,7843,9990-3,999
SAVARA INC(SVRA)17,600,62117,600,621048,75440,1295.02%-8,624
DISC MEDICINE INC(IRON)983,500583,500-400,00048,82130,9023.87%-17,919
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
10,719,11010,719,1100219,420194,12324.29%-25,297
Page 1 of 1